The short version
18 companies supply this market — deep enough that no single failure threatens the supply. The price has fallen 39% in a year, to $5.00 per mL — and generics that get this cheap tend to get abandoned rather than defended. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).